Will nirsevimab be the holy grail for prevention of respiratory syncytial virus lower respiratory tract infections in infants?

被引：2
作者：
Homaira, Nusrat [1 ,2 ,3 ,4 ]
机构：
[1] UNSW Sydney, Fac Med, Sch Clin Med, Discipline Paediat & Child Hlth, Randwick, NSW, Australia
[2] Sydney Childrens Hosp, Resp Dept, Randwick, NSW, Australia
[3] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh
[4] UNSW Sydney, Fac Med, Ctr Child Hlth Res & Innovat ChERI, Discipline Paediat & Child Hlth,Bright Alliance,Sc, Level-8, Randwick, NSW 2031, Australia
来源：
TRANSLATIONAL PEDIATRICS | 2024年 / 13卷 / 03期
关键词：
Respiratory syncytial virus (RSV); respiratory syncytial virus prophylaxis (RSV prophylaxis); monoclonal antibody; nirsevimab; infants; YOUNG-CHILDREN; RISK-FACTORS; RSV; HOSPITALIZATION; PRETERM; DISEASE; BURDEN;
D O I：
10.21037/tp-23-534
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：525 / 529
页数：5
相关论文
共 28 条
[1]   Risk Factors and Viruses Associated With Hospitalization Due to Lower Respiratory Tract Infections in Canadian Inuit Children A Case-Control Study [J].
Banerji, Anna ;
Greenberg, David ;
White, Laura Forsberg ;
Macdonald, W. Alexander ;
Saxton, Audrey ;
Thomas, Eva ;
Sage, Douglas ;
Mamdani, Muhammad ;
Lanctot, Krista L. ;
Mahony, James B. ;
Dingle, Mia ;
Roberts, Ann .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (08) :697-701
[2]  
Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1666, 10.1542/peds.2014-1665]
[3]   Risk factors for severe respiratory syncytial virus infection among Alaska Native children [J].
Bulkow, LR ;
Singleton, RJ ;
Karron, RA ;
Harrison, LH .
PEDIATRICS, 2002, 109 (02) :210-216
[4]   Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes [J].
Cai, Wei ;
Buda, Silke ;
Schuler, Ekkehard ;
Hirve, Siddhivinayak ;
Zhang, Wenqing ;
Haas, Walter .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2020, 14 (06) :658-670
[5]   Burden of Respiratory Syncytial Virus in the European Union: estimation of RSV-associated hospitalizations in children under 5 years [J].
Del Riccio, Marco ;
Spreeuwenberg, Peter ;
Osei-Yeboah, Richard ;
Johannesen, Caroline K. ;
Fernandez, Liliana Vazquez ;
Teirlinck, Anne C. ;
Wang, Xin ;
Heikkinen, Terho ;
Bangert, Mathieu ;
Caini, Saverio ;
Campbell, Harry ;
Paget, John .
JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (11) :1528-1538
[6]   Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018 [J].
Demont, C. ;
Petrica, N. ;
Bardoulat, I ;
Duret, S. ;
Watier, L. ;
Chosidow, A. ;
Lorrot, M. ;
Kieffer, A. ;
Lemaitre, M. .
BMC INFECTIOUS DISEASES, 2021, 21 (01)
[7]   Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity [J].
Domachowske, Joseph ;
Madhi, Shabir A. ;
Simoes, Eric A. F. ;
Atanasova, Victoria .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (09) :892-894
[8]   Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: a cross-sectional study of nationally representative facility-based and household-based surveys [J].
Fink, Gunther ;
D'Acremont, Valerie ;
Leslie, Hannah H. ;
Cohen, Jessica .
LANCET INFECTIOUS DISEASES, 2020, 20 (02) :179-187
[9]   Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants [J].
Griffin, M. Pamela ;
Yuan, Yuan ;
Takas, Therese ;
Domachowske, Joseph B. ;
Madhi, Shabir A. ;
Manzoni, Paolo ;
Simoes, Eric A. F. ;
Esser, Mark T. ;
Khan, Anis A. ;
Dubovsky, Filip ;
Villafana, Tonya ;
DeVincenzo, John P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05) :415-425
[10]   Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants [J].
Hammitt, Laura L. ;
Dagan, Ron ;
Yuan, Yuan ;
Cots, Manuel Baca ;
Bosheva, Miroslava ;
Madhi, Shabir A. ;
Muller, William J. ;
Zar, Heather J. ;
Brooks, Dennis ;
Grenham, Amy ;
Hamren, Ulrika Wahlby ;
Mankad, Vaishali S. ;
Ren, Pin ;
Takas, Therese ;
Abram, Michael E. ;
Leach, Amanda ;
Griffin, M. Pamela ;
Villafana, Tonya .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (09) :837-846
123